Locations:
Search IconSearch

Innovating With Clinical Intent Through Tech-Enabled Data Capture (Podcast)

The future of neurological care resides in harnessing big data sets

Biomechanics has come a long way. One of the first biomechanics studies was done to settle a bet over whether the four hooves of a galloping horse are ever all off the ground at once. Today the field has evolved to the point where common consumer electronic devices pack enough computing power to enable capture of patients’ functional data at a scale large enough to fuel disease prediction algorithms.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Jay Alberts, PhD, is a biomedical engineer at the forefront of such tech-enabled data capture. In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, he shares insights on how it is accelerating progress in biomechanics — and how it will be shaping the clinical care of patients with neurological diseases.

Dr. Alberts, Vice Chair of Innovation in Cleveland Clinic’s Neurological Institute, covers a wealth of subtopics, including:

  • Use of the iPad and other consumer electronics to objectively quantify cognitive and motor function
  • Why it’s essential to develop such tools with clear and explicit clinical intent
  • How suboptimal data quality has slowed the advancement of artificial intelligence in healthcare
  • How clinicians and engineers can best collaborate to harness technological potential

Click the player below to listen to the 17-minute podcast now, or read on below for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Alberts: We’ve done a lot around the question of how we can use consumer electronic devices to objectively quantify cognitive and motor function. I think the important part here is that we’re looking at both cognitive and motor functions simultaneously, as opposed to each in a silo. That has really led us to improve in terms of the treatment of Parkinson’s disease patients and optimizing deep brain stimulation [DBS] parameters.

So in the post-DBS setting, rather than looking at a patient just in terms of the cognitive domain and then sending them across the hall to have the neurologist do a traditional UPDRS, we’re now able to use both cognitive and motor function simultaneously to help program these patients’ DBS parameters. That’s really an important aspect because activities of daily living have both a cognitive component and a motor component, whether you’re walking across the street, carrying a cup of coffee or engaging in a conversation. You’re processing the information in terms of questions like, Is this car coming? or Are they going to stop? And then you have to monitor your motor performance as well.

Advertisement

I think that’s where we have been able to leverage some of the work we’ve done with consumer electronics to bring these types of tools to the clinic and the provider.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad